Response to Mobocertinib in a patient with advanced Non-Small Cell Lung Cancer harboring EGFR exon 20 insertion after several therapies including Amivantamab

  1. Corral de la Fuente, E.
  2. Olmedo García, M.E.
  3. Orejana Martín, I.
  4. Benito Berlinches, A.
  5. Gómez Rueda, A.
  6. Lage Alfranca, Y.
  7. Garrido, P.
Journal:
Current Problems in Cancer: Case Reports

ISSN: 2666-6219

Year of publication: 2022

Volume: 5

Type: Article

DOI: 10.1016/J.CPCCR.2022.100145 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals